Cannabix Technologies Announces First Sale of BreathLogix Alcohol Screening Device to Maritime Market
Cannabix Technologies (OTC:BLOZF) has achieved its first sale of the BreathLogix unmanned alcohol screening technology to a European maritime shipping company. The system, which includes cloud-based "BreathLogix Connect" platform powered by AWS, features facial recognition and provides real-time alerts for crew safety monitoring.
The announcement follows the company's first commercial production run and recent NHTSA approval for the BreathLogix "Workplace Series" device. The technology delivers precise BAC measurements, enables real-time test reporting, and features patent-pending pre-calibrated sensor cartridge technology for easy maintenance. The system can integrate with various access control systems and supports multiple testing scenarios including pre-access, start-of-shift, and random testing.
Cannabix Technologies (OTC:BLOZF) ha ottenuto la prima vendita della tecnologia di screening dell'alcool BreathLogix unmanned a una società europea di trasporto marittimo. Il sistema, che include la piattaforma cloud-based "BreathLogix Connect" supportata da AWS, presenta riconoscimento facciale e fornisce avvisi in tempo reale per il monitoraggio della sicurezza dell'equipaggio.
L'annuncio segue la prima produzione commerciale dell'azienda e l'approvazione recente da parte della NHTSA per il dispositivo BreathLogix "Workplace Series". La tecnologia offre misurazioni precise del BAC, consente la redazione di report dei test in tempo reale e presenta una tecnologia di cartuccia sensore pre-calibrata, in attesa di brevetto, per una facile manutenzione. Il sistema può integrarsi con diversi sistemi di controllo accessi e supporta molteplici scenari di testing, tra cui pre-accesso, inizio turno e test casuali.
Cannabix Technologies (OTC:BLOZF) ha logrado su primera venta de la tecnología de cribado de alcohol sin personal BreathLogix a una empresa europea de transporte marítimo. El sistema, que incluye la plataforma en la nube "BreathLogix Connect" impulsada por AWS, cuenta con reconocimiento facial y ofrece alertas en tiempo real para la supervisión de la seguridad de la tripulación.
El anuncio sigue a la primera producción comercial de la compañía y a la reciente aprobación de la NHTSA para el dispositivo BreathLogix de la serie "Workplace Series". La tecnología ofrece mediciones precisas de BAC, permite informes de pruebas en tiempo real y presenta una tecnología de cartucho sensor pre-calibrado con patente en trámite para facilitar el mantenimiento. El sistema puede integrarse con diversos sistemas de control de acceso y admite múltiples escenarios de prueba, incluidos preacceso, inicio de turno y pruebas aleatorias.
Cannabix Technologies (OTC:BLOZF) 가 BreathLogix 무인 음주 측정 기술의 첫 판매를 유럽 해양 운송 회사에 달성했습니다. 시스템은 AWS가 지원하는 클라우드 기반 플랫폼 "BreathLogix Connect"를 포함하며 얼굴 인식 기능과 선원 안전 모니터링을 위한 실시간 경보를 제공합니다.
발표는 회사의 첫 상용 생산과 BreathLogix "Workplace Series" 장치에 대한 NHTSA 승인을 따른 것입니다. 이 기술은 정확한 BAC 측정치를 제공하고 실시간 테스트 보고를 가능하게 하며, 유지보수를 용이하게 하는 특허 대기 중인 사전 보정 센서 카트리지 기술을 특징으로 합니다. 시스템은 다양한 출입 통제 시스템과 통합될 수 있으며 사전 접근, 교대 시작, 무작위 테스트를 포함한 여러 테스트 시나리오를 지원합니다.
Cannabix Technologies (OTC:BLOZF) a réalisé sa première vente de la technologie de dépistage alcoolémique sans personnel BreathLogix à une société européenne de transport maritime. Le système, qui comprend la plateforme cloud "BreathLogix Connect" propulsée par AWS, intègre la reconnaissance faciale et fournit des alertes en temps réel pour la surveillance de la sécurité de l'équipage.
L'annonce fait suite à la première production commerciale de l'entreprise et à l'approbation récente par la NHTSA du dispositif BreathLogix de la série "Workplace Series". La technologie offre des mesures précises du taux d'alcoolémie (BAC), permet des rapports de tests en temps réel et présente une technologie de cartouche de capteur pré-calibrée, en attente de brevet, pour faciliter l'entretien. Le système peut s'intégrer à divers systèmes de contrôle d'accès et prend en charge plusieurs scénarios de test, notamment pré-accès, début de poste et tests aléatoires.
Cannabix Technologies (OTC:BLOZF) hat den ersten Verkauf der BreathLogix-Unmanned-Alkoholscreening-Technologie an ein europäisches Seefrachtunternehmen erzielt. Das System umfasst die cloudbasierte Plattform "BreathLogix Connect" betrieben von AWS, verfügt über Gesichtserkennung und bietet Echtzeitwarnungen zur Besatzungssicherheit.
Die Ankündigung folgt auf die erste kommerzielle Produktionslauf und die jüngste NHTSA-Zulassung für das BreathLogix "Workplace Series"-Gerät. Die Technologie liefert präzise BAC-Messungen, ermöglicht Echtzeit-Testberichte und präsentiert eine patentanstehende vorab kalibrierte Sensor-Kartuschen-Technologie zur einfachen Wartung. Das System kann mit verschiedenen Zugangskontrollsystemen integriert werden und unterstützt mehrere Test-Szenarien, einschließlich Pre-Access, Start der Schicht und zufälliger Tests.
Cannabix Technologies (OTC:BLOZF) حققت أول بيع لتقنية فحص الكحول BreathLogix بدون طاقم إلى شركة شحن بحري أوروبية. النظام، الذي يشمل منصة سحابية "BreathLogix Connect" مدعومة من AWS، يتميز بميزة التعرف على الوجه ويقدم تنبيهات فورية لمراقبة سلامة الطاقم.
الإعلان يأتي بعد أول إنتاج تجاري للشركة والتصديق الأخير من NHTSA لجهاز BreathLogix من سلسلة "Workplace Series". التقنية توفر قياسات BAC دقيقة، وتتيح تقارير فحص في الوقت الفعلي وتحتوي على تكنولوجيا خراطيش مستشعرات قبل المعايرة براءة اختراع قيد الانتظار لسهولة الصيانة. النظام يمكنه التكامل مع أنظمة وصول مختلفة ويدعم سيناريوهات فحص متعددة بما في ذلك ما قبل الوصول وبداية الوردية والفحوص العشوائية.
Cannabix Technologies (OTC:BLOZF) 已向欧洲一家海运公司推出 BreathLogix 无人酒精筛查技术的首笔销售。该系统包括由 AWS 支持的云端“BreathLogix Connect”平台，具备人脸识别并为船员安全监控提供实时警报。
公告紧随公司首次商业生产阶段及最近获得的 NHTSA 对 BreathLogix “Workplace Series”设备的批准。该技术能够提供精确的 BAC 测量、实现实时测试报告，并具备专利待批的预校准传感器筒技术以便维护。系统可与多种门禁系统集成，并支持包括预进入、班前开始、随机测试在内的多种测试场景。
- First commercial sale achieved for BreathLogix technology
- NHTSA approval obtained for BreathLogix Workplace Series device
- Patent-pending pre-calibrated sensor technology reduces maintenance costs
- Cloud-based platform enables real-time monitoring and reporting
- Company not currently generating significant revenue from breathalyzer sales
- Faces potential regulatory and market adoption challenges
- Early stage of commercialization with uncertain market acceptance
VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it has entered into its first sale agreement for its BreathLogix unmanned alcohol screening technology. The Company will be delivering its BreathLogix technology to a European maritime shipping company that is seeking to increase operational safety amongst its crew members with pre-access breath alcohol testing. The system will be integrated with the cloud-based “BreathLogix Connect” platform, powered by Amazon Web Services, enabling real-time alerts, centralized data management, and seamless reporting. Additionally, the device will integrate facial recognition technology for rapid and secure crew member identification. The BreathLogix alcohol testing solution is targeted to various industries including mining, oil and gas, industrial, trucking, warehousing and maritime vessels to enhance operational safety.
Figure 1. BreathLogix Alcohol device available with contactless and straw modes for rapid workplace pre-access alcohol screening
This announcement comes on the heels of the Company completing its first commercial production run commenced this summer. Earlier this year, the Company’s BreathLogix “Workplace Series” device was approved by National Highway Traffic Safety Association (NHTSA) to be added to the U.S. Federal Register Conforming Products List (CPL) for breath alcohol screen devices.
BreathLogix unmanned alcohol screening devices rapidly check for breath alcohol and simultaneously takes a photo of the user to help confirm and record identity (Figure 1 and 2). The device delivers precise Blood Alcohol Content (BAC or BrAC) levels on the screen and sends real-time test reports via SMS and e-mail, alerting managers to positive BAC results so they can take immediate action to avoid damage and injury. All test results are logged and managed on a dedicated ‘BreathLogix Connect’ web portal. BreathLogix can be integrated with doors, turnstiles, gates, facial recognition, fingerprint readers and motor vehicle key fleet management systems for pre-access alcohol testing. Furthermore, the device can be used for start-of-shift testing, mandated testing, pre-employment testing, return-to-work testing, random and post-incident testing.
BreathLogix includes patent pending pre-calibrated sensor cartridge technology allowing administrators to easily maintain their devices and eliminate the need for costly calibration equipment and time-consuming site visits from technicians for maintenance.
Figure 2. BreathLogix Alcohol Screening Devices by Cannabix Technologies Inc.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEO
Cannabix Technologies Inc.
For further information, contact the Company at info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates," "plan," "continue," "expect," "project," "intend," "believe," "anticipate," "estimate," "may," "will," "potential," "proposed," "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include, but are not limited to, statements relating to: certification of devices, acceptance of devices by international regulators, the achievement of any or all of the goals and aims of the distribution and sales agreement with any third-party companies; positive developments with contract manufacturers; the completion of pre-validation or validation testing; final development of a commercial or prototype product(s); the successful trial or pilot of company technologies; the commercialization of the Company's products; the negotiation and potential entry into additional agreements with distributors and or contract manufacturers; and the completion of future financings. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Important factors that could cause actual results to differ materially from those expressed in the forward-looking information include (but are note limited to): adverse market conditions; risks regarding protection of proprietary technology; the ability of the Company to complete future financings; the ability of the Company to develop and market its future product; risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition; that the Company’s development of cannabis and alcohol breathalyzer technologies will provide any benefit to the Company; there is no assurance that any proposed new products will be built, will be successful in beta testing or clinical trials; there is no assurance that the Company will enter into any partnerships to advance any of its corporate initiatives or technologies; there is no assurance that any “patent pending” or “provisional patents” technologies licensed by the Company or owned by the Company will receive patent status by regulatory authorities; the Company is not currently selling breathalyzers and there is no assurance that the Company ever will; and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/59cd5cac-ac7d-410b-8727-8e47fd0421e0
https://www.globenewswire.com/NewsRoom/AttachmentNg/d20cd862-d699-4a2b-ac4d-e0218cef6e9f
FAQ
What is the significance of Cannabix Technologies' first BreathLogix sale?
What certifications has the BreathLogix device received?
What are the key features of the BreathLogix alcohol screening system?
How does the BreathLogix Connect platform work?
What industries is BreathLogix targeting?
